Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Lexaria Bioscience Corp. (LEXX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Bought 1,500 shares
@ $2.8446, valued at
$4.3k
|
|
| 10/18/2022 |
4
| Downey Gregory (CFO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 121 shares
@ $2.09, valued at
$252.9 |
|
| 10/13/2022 |
4
| McKechnie William Edward (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 18,200 options
@ $1.96, valued at
$35.7k
|
|
| 10/13/2022 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,200 options
@ $1.96, valued at
$6.3k
|
|
| 10/13/2022 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,600 options
@ $1.96, valued at
$3.1k
|
|
| 10/13/2022 |
4
| BUNKA CHRISTOPHER (CEO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 21,900 shares
@ $1.988, valued at
$43.5k
Granted 16,600 shares
@ $2.1, valued at
$34.9k
|
|
| 10/13/2022 |
4
| Baxter Nicholas W (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 18,200 options
@ $1.96, valued at
$35.7k
|
|
| 09/06/2022 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $3.04, valued at
$10.3k
|
|
| 08/29/2022 |
4
| Carle Vanessa (Secretary) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 12,500 options
@ $2.91, valued at
$36.4k
|
|
| 08/29/2022 |
4
| DOCHERTY JOHN MARTIN (President) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 30,000 options
@ $2.91, valued at
$87.3k
|
|
| 08/29/2022 |
4
| BUNKA CHRISTOPHER (CEO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 30,000 options
@ $2.91, valued at
$87.3k
|
|
| 08/29/2022 |
4
| Downey Gregory (CFO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 11,000 options
@ $2.91, valued at
$32k
|
|
| 05/25/2022 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 5,000 shares
@ $1.958, valued at
$9.8k
|
|
| 05/24/2022 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,799 shares
@ $2.007, valued at
$3.6k
|
|
| 05/19/2022 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,700 shares
@ $2.008, valued at
$3.4k
Granted 1,501 shares
@ $2.01, valued at
$3k
|
|
| 03/08/2022 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $3.39, valued at
$11.5k
|
|
| 03/08/2022 |
4
| McKechnie William Edward (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $3.39, valued at
$11.5k
|
|
| 03/08/2022 |
4
| Baxter Nicholas W (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $3.39, valued at
$11.5k
|
|
| 09/02/2021 |
4
| BUNKA CHRISTOPHER (CEO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 15,000 options
@ $6.23, valued at
$93.5k
|
|
| 09/02/2021 |
4
| DOCHERTY JOHN MARTIN (President) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 15,000 options
@ $6.23, valued at
$93.5k
|
|
| 09/02/2021 |
4
| McKechnie William Edward (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,900 options
@ $6.23, valued at
$11.8k
|
|
| 09/02/2021 |
4
| Baxter Nicholas W (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 1,900 options
@ $6.23, valued at
$11.8k
|
|
| 09/02/2021 |
4
| Downey Gregory (CFO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 10,000 options
@ $6.23, valued at
$62.3k
|
|
| 09/02/2021 |
4
| Carle Vanessa (Secretary) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 10,000 options
@ $6.23, valued at
$62.3k
|
|
| 07/21/2021 |
4
| REESE ALBERT L JR (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 3,400 options
@ $4.8, valued at
$16.3k
|
|
| 06/09/2021 |
4
| DOCHERTY JOHN MARTIN (President) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 18,334 options
@ $7.08, valued at
$129.8k
|
|
| 06/09/2021 |
4
| DOCHERTY JOHN MARTIN (President) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Disposed of 18,334 options
@ $14.1, valued at
$258.5k
|
|
| 06/09/2021 |
4
| McKechnie William Edward (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 5,000 options
@ $7.08, valued at
$35.4k
|
|
| 06/09/2021 |
4
| McKechnie William Edward (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Disposed of 5,000 options
@ $9.6, valued at
$48k
|
|
| 06/09/2021 |
4
| BUNKA CHRISTOPHER (CEO) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Granted 23,334 options
@ $7.08, valued at
$165.2k
|
|
|
|
|